A multidisciplinary committee of experts studied the scientific underpinnings of human gene-editing technologies, their potential use in biomedical research and medicine -- including human germline ...
The US Food and Drug Administration released a draft guidance document on Tuesday with recommendations for using ...
An international group of scientists is calling for a moratorium on making inheritable changes to the human genome, specifically the use of the Crisper-Cas9 technique on DNA. The group met in ...
A research team has discovered an enhanced CRISPR gene-editing system that could enable targeted delivery inside the human ...
The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
CRISPR functions as a programmable genetic memory system derived from bacterial immune defenses against viral infections. Guide RNA allows for rapid multiplexed targeting compared to older ...
New Haven, Conn. — The promise of genome editing to help understand human diseases and create new therapies is vast, but technological limitations have limited advancement of the field. While existing ...
The US Food and Drug Administration (FDA) has issued two draft guidances addressing the development of human gene therapy products that incorporate genome editing of human somatic cells and chimeric ...
A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results